The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic significance of the chemokine CXCL13 in node-negative breast cancer.
Marcus Schmidt
No relevant relationships to disclose
Leonie van de Sandt
No relevant relationships to disclose
Daniel Boehm
No relevant relationships to disclose
Isabel Sicking
No relevant relationships to disclose
Marco Johannes Battista
No relevant relationships to disclose
Antje Lebrecht
No relevant relationships to disclose
Christine Solbach
No relevant relationships to disclose
Gert Naumann
No relevant relationships to disclose
Joerg Rahnenfuehrer
No relevant relationships to disclose
Ralph M Wirtz
No relevant relationships to disclose
Jan G Hengstler
No relevant relationships to disclose